Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Fellay, J.; Boubaker, K.; Ledergerber, B.; Bernasconi, E.; Furrer, H.; Battegay, M.; Hirschel, B.; Vernazza, P.; Francioli, P.; Greub, G.; Flepp, M.; Telenti, A.
2001

Abstract

Data on adverse events to antiretroviral treatment have been recorded in clinical trials, post-marketing analyses, and anecdotal reports. Such data might not be an up-to-date or comprehensive assessment of all possible treatment combinations defined as potent antiretroviral treatment.

Details

Title Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Author(s) Fellay, J. ; Boubaker, K. ; Ledergerber, B. ; Bernasconi, E. ; Furrer, H. ; Battegay, M. ; Hirschel, B. ; Vernazza, P. ; Francioli, P. ; Greub, G. ; Flepp, M. ; Telenti, A.
Published in Lancet
Volume 358
Issue 9290
Pages 1322-7
Date 2001
Publisher Elsevier
ISSN 0140-6736
Note Erratum in: Lancet 2001 Dec 15;358(9298):2088.
DOI https://doi.org/10.1016/S0140-6736(01)06413-3
Laboratories GR-FE
Record Appears in Scientific production and competences > SV - School of Life Sciences > GHI - Global Health Institute > GR-FE - Fellay Group
Peer-reviewed publications
Work outside EPFL
Journal Articles
Published
Record creation date 2011-04-15

Actions